###begin article-title 0
###xml 95 111 95 111 <italic>Escherichia coli</italic>
###xml 95 111 <span type="species:ncbi:562">Escherichia coli</span>
Computer-aided rational design of the phosphotransferase system for enhanced glucose uptake in Escherichia coli
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution and reproduction in any medium, provided the original author and source are credited. Creation of derivative works is permitted but the resulting work may be distributed only under the same or similar licence to this one. This licence does not permit commercial exploitation without specific permission.
###end p 1
###begin p 2
###xml 295 311 295 311 <italic>Escherichia coli</italic>
###xml 892 895 892 895 <italic>mlc</italic>
###xml 917 921 917 921 <italic>ptsI</italic>
###xml 295 311 <span type="species:ncbi:562">Escherichia coli</span>
The phosphotransferase system (PTS) is the sugar transportation machinery that is widely distributed in prokaryotes and is critical for enhanced production of useful metabolites. To increase the glucose uptake rate, we propose a rational strategy for designing the molecular architecture of the Escherichia coli glucose PTS by using a computer-aided design (CAD) system and verified the simulated results with biological experiments. CAD supports construction of a biochemical map, mathematical modeling, simulation, and system analysis. Assuming that the PTS aims at controlling the glucose uptake rate, the PTS was decomposed into hierarchical modules, functional and flux modules, and the effect of changes in gene expression on the glucose uptake rate was simulated to make a rational strategy of how the gene regulatory network is engineered. Such design and analysis predicted that the mlc knockout mutant with ptsI gene overexpression would greatly increase the specific glucose uptake rate. By using biological experiments, we validated the prediction and the presented strategy, thereby enhancing the specific glucose uptake rate.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
The goals of systems biology are to understand the mechanism of how biochemical networks generate particular cellular functions in response to environmental stresses or genetic changes, and to rationally design the molecular processes to meet an engineering purpose. Robustness, which is an inherent property for cells to maintain homeostasis against a variety of environmental stresses, genetic changes, and stochastic fluctuations, is the key feature to analyze or design the molecular architecture that produces various cellular functions.
###end p 4
###begin p 5
In the field of biotechnology, there have been many studies that aimed at producing useful metabolites using genetically engineered organisms, which often require a rational strategy of how the molecular processes of complex and robust cells are designed in order to achieve enhanced production. Since various mechanisms generating robustness, such as pathway redundancy and feedback (FB) regulation, often cancel the effect of genetic manipulations, it is important to understand the molecular mechanism of how a biochemical network generates robustness to genetic perturbations.
###end p 5
###begin p 6
###xml 444 449 444 449 <italic>et al</italic>
###xml 437 455 437 455 <xref ref-type="bibr" rid="b24">Kurata <italic>et al</italic>, 2005</xref>
To rationally design biological systems at the molecular interaction level, it is essential to identify a biochemical network map, to build a dynamic model of the system, and to perform system analysis, thereby linking the molecular architecture to cellular functions. Computer-aided design (CAD) is now a key concept in building dynamic models and to mathematically simulate the molecular architecture of a genetically engineered cell (Kurata et al, 2005). Perturbation analysis is useful for identifying critical parameters that affect the system's performance. To modify the metabolism using biotechnology, the most common and convenient methodology for perturbation analysis is changing the copy number of metabolic pathway coding genes by using genetic recombination technology. Most of the previous metabolic engineering studies proposed qualitative alternations of the nature of enzymes or metabolite concentrations in cells.
###end p 6
###begin p 7
###xml 219 224 219 224 <italic>et al</italic>
###xml 212 230 212 230 <xref ref-type="bibr" rid="b23">Kurata <italic>et al</italic>, 2006</xref>
Furthermore, module-based analysis has been presented that decomposes a biochemical network map into hierarchical modules, functional and flux modules, in a manner analogous to control engineering architectures (Kurata et al, 2006). If an engineering purpose is provided for a biochemical network, functional modules are readily determined and an engineering function can be assigned to each module. This greatly facilitates the rational design of a genetic manipulation responsible for achieving the desired outcome, and provides an intuitive understanding of how the biochemical network of interest is improved or modified.
###end p 7
###begin p 8
###xml 183 199 183 199 <italic>Escherichia coli</italic>
###xml 294 305 294 305 <xref ref-type="bibr" rid="b16">Ikeda, 2003</xref>
###xml 335 340 335 340 <italic>et al</italic>
###xml 326 346 326 346 <xref ref-type="bibr" rid="b52">Wendisch <italic>et al</italic>, 2006</xref>
###xml 649 654 649 654 <italic>et al</italic>
###xml 642 660 642 660 <xref ref-type="bibr" rid="b42">Rohwer <italic>et al</italic>, 2000</xref>
###xml 662 688 662 688 <xref ref-type="bibr" rid="b49">Thattai and Shraiman, 2003</xref>
###xml 690 713 690 713 <xref ref-type="bibr" rid="b45">Sauter and Gilles, 2004</xref>
###xml 725 730 725 730 <italic>et al</italic>
###xml 715 736 715 736 <xref ref-type="bibr" rid="b41">Rodriguez <italic>et al</italic>, 2006</xref>
###xml 746 751 746 751 <italic>et al</italic>
###xml 739 758 739 758 <xref ref-type="bibr" rid="b42">Rohwer <italic>et al</italic> (2000)</xref>
###xml 798 805 798 805 <italic>E. coli</italic>
###xml 892 899 892 899 <italic>E. coli</italic>
###xml 901 925 901 925 <xref ref-type="bibr" rid="b45">Sauter and Gilles (2004)</xref>
###xml 183 199 <span type="species:ncbi:562">Escherichia coli</span>
###xml 798 805 <span type="species:ncbi:562">E. coli</span>
###xml 892 899 <span type="species:ncbi:562">E. coli</span>
In the field of industrial production of useful substances by microorganisms, glucose (Glc) is one of the most important substrates necessary for substance production or cell growth. Escherichia coli is a commonly used microbe in the industrial field, including the manufacture of amino acids (Ikeda, 2003) and organic acids (Wendisch et al, 2006). To enhance the ability to utilize substrates is of critical importance to increase the productivity of useful substances from the viewpoint of economical impact. Based on biological knowledge of the phosphotransferase system (PTS), several modeling and simulation studies have been performed (Rohwer et al, 2000; Thattai and Shraiman, 2003; Sauter and Gilles, 2004; Rodriguez et al, 2006). Rohwer et al (2000) measured the kinetic parameters of the E. coli glucose PTS and built the enzymatic reaction model. To study catabolite repression in E. coli, Sauter and Gilles (2004) developed a numerical model describing the transport and signal processing function by the sucrose PTS, validating their model with several experiments.
###end p 8
###begin p 9
###xml 140 147 140 147 <italic>E. coli</italic>
###xml 468 476 468 476 <xref ref-type="fig" rid="f1">Figure 1</xref>
###xml 719 723 719 723 <italic>ptsG</italic>
###xml 725 729 725 729 <italic>ptsH</italic>
###xml 731 735 731 735 <italic>ptsI</italic>
###xml 737 740 737 740 <italic>crr</italic>
###xml 742 746 742 746 <italic>cyaA</italic>
###xml 748 751 748 751 <italic>crp</italic>
###xml 757 760 757 760 <italic>mlc</italic>
###xml 769 774 769 774 <italic>et al</italic>
###xml 762 780 762 780 <xref ref-type="bibr" rid="b24">Kurata <italic>et al</italic>, 2005</xref>
###xml 140 147 <span type="species:ncbi:562">E. coli</span>
To perform perturbation analysis or to analyze the effect of the copy number of genes, we constructed an extended mathematical model of the E. coli glucose PTS model including the transcriptional regulation of the PTS proteins. The final objective was to increase the fermentation productivity through genetic improvement of glucose uptake efficiency in the PTS model. We propose a general strategy for computer-aided rational design of biochemical models as shown in Figure 1. CAD supports construction of a biochemical network map, mathematical modeling, dynamic simulation, and system analysis. Using the CADLIVE system we designed the molecular architecture of the glucose PTS that consists of the following genes: ptsG, ptsH, ptsI, crr, cyaA, crp, and mlc (Kurata et al, 2005). In order to make a rational plan of how the PTS could be genetically engineered for an enhanced glucose uptake rate, or to determine which genes should be deleted or overexpressed, the PTS was decomposed into hierarchical modules, functional and flux modules, in a manner analogous to control engineering architectures, and subsequently the effects of changes in gene expression on the glucose uptake rate were simulated to predict which genes are critical for enhanced uptake. Finally we validated the predicted performance of rationally engineered cells with experimental results, demonstrating the feasibility of the computer-aided rational design of biochemical networks.
###end p 9
###begin title 10
Results and discussion
###end title 10
###begin title 11
Modular architecture of the glucose PTS and mathematical modeling
###end title 11
###begin p 12
###xml 36 43 36 43 <italic>E. coli</italic>
###xml 57 65 57 65 <xref ref-type="fig" rid="f2">Figure 2</xref>
###xml 112 142 112 142 <xref ref-type="supplementary-material" rid="S1">Supplementary Tables S1 and S2</xref>
###xml 201 206 201 206 <italic>et al</italic>
###xml 194 212 194 212 <xref ref-type="bibr" rid="b24">Kurata <italic>et al</italic>, 2005</xref>
###xml 281 286 281 286 <italic>et al</italic>
###xml 274 292 274 292 <xref ref-type="bibr" rid="b25">Kurata <italic>et al</italic>, 2003</xref>
###xml 610 619 610 619 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 639 648 639 648 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 716 721 716 721 <italic>et al</italic>
###xml 709 727 709 727 <xref ref-type="bibr" rid="b23">Kurata <italic>et al</italic>, 2006</xref>
###xml 792 795 792 795 <sup>Glc</sup>
###xml 797 801 797 801 <italic>ptsG</italic>
###xml 807 810 807 810 <sup>Glc</sup>
###xml 812 815 812 815 <italic>crr</italic>
###xml 823 827 823 827 <italic>ptsH</italic>
###xml 838 842 838 842 <italic>ptsI</italic>
###xml 992 995 992 995 <sup>Glc</sup>
###xml 1284 1287 1284 1287 <sup>Glc</sup>
###xml 1607 1610 1607 1610 <sup>Glc</sup>
###xml 36 43 <span type="species:ncbi:562">E. coli</span>
We present a biochemical map of the E. coli glucose PTS (Figure 2) and developed a dynamic model from this map (Supplementary Tables S1 and S2; see also Materials and methods) by using CADLIVE (Kurata et al, 2005). Details of the graphical notation are described elsewhere (Kurata et al, 2003). Generally, it is of great importance to increase the sugar uptake rate for enhanced substance production. We aimed at increasing the glucose uptake rate. To assign a particular function to each gene in terms of an enhanced uptake rate, the biochemical map of the glucose PTS was decomposed into functional modules (Figure 2A) and flux modules (Figure 2B) analogous to an engineering control systems block diagram (Kurata et al, 2006). Specifically, if we define the phosphotransfer cascade of IICBGlc (ptsG), IIAGlc (crr), HPr (ptsH), and EI (ptsI) as the plant to be controlled, then the entity that drives this plant is the signal from the accelerator actuator. The phosphorylation signal of IIAGlc-P is sensed by the FB sensor module and sent to the computer module that consists of adenylate cyclase (CYA), cyclic AMP (cAMP), and cAMP receptor protein (CRP), while it is also transmitted to the signal transduction pathways to enhance other carbon transport systems. The complex of IIAGlc-P:CYA, which is formed in the FB sensor module, produces the cAMP signal in the computer module, resulting in the formation of CRP:cAMP. CRP:cAMP is the output of the computer module, which modulates the accelerator and brake actuator modules. The accelerator actuator module comprises the synthesis process of the IICBGlc, HPr, and EI proteins, supplying these PTS proteins to the plant module; the brake actuator module of the Making Large Colonies Protein (Mlc) suppresses the synthesis of the same PTS proteins.
###end p 12
###begin p 13
###xml 247 256 247 256 <xref ref-type="fig" rid="f2">Figure 2A</xref>
###xml 334 337 334 337 <sup>Glc</sup>
###xml 458 461 458 461 <sup>Glc</sup>
###xml 476 485 476 485 <xref ref-type="fig" rid="f2">Figure 2B</xref>
###xml 559 562 559 562 <sup>Glc</sup>
Superimposed on these functional modules, we identify two major flux modules, the accelerator flux module and the brake flux module. Although our description of these fluxes is qualitative, the components of the fluxes can be easily identified in Figure 2A. First, we identified the accelerator flux module where the signal of the IIAGlc-P increase goes through the FB sensor, computer, accelerator actuator, and plant modules to induce the synthesis of IICBGlc, HPr, and EI (Figure 2B). Second, we identified the brake flux module where the signal of the IIAGlc-P increase goes through the FB sensor, computer, brake actuator, accelerator actuator, and plant modules, which regulates the PTS component synthesis by suppressing the accelerator actuator.
###end p 13
###begin p 14
###xml 111 114 111 114 <sup>Glc</sup>
###xml 155 158 155 158 <sup>Glc</sup>
We provide an example of the signal processing under glucose depletion conditions. Since the phosphorous of IIAGlc-P is not transferred to glucose, the IIAGlc-P concentration immediately increases. The sensor module then assesses an increase in the signal molecule, transmitting its information to the computer module. The computer module calculates the output signal necessary for an adequate control action, which is transmitted simultaneously to the accelerator actuator module and the brake actuator module. The phosphotransfer activity in the plant module is determined by the balance between the accelerator and brake actuator modules.
###end p 14
###begin p 15
###xml 90 112 90 112 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 153 175 153 175 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 289 311 289 311 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 506 509 506 509 <italic>crp</italic>
###xml 514 518 514 518 <italic>cyaA</italic>
###xml 779 783 779 783 <italic>ptsG</italic>
###xml 785 789 785 789 <italic>ptsH</italic>
###xml 791 795 791 795 <italic>ptsI</italic>
###xml 801 804 801 804 <italic>crr</italic>
The mathematical equations can be connected to the functional modules for the full model (Supplementary Table S1). In this model, Equations (1.1-1.8) in Supplementary Table S1 describe the plant module, which corresponds to the phosphotransfer reactions in the PTS. Equations (2.1-2.3) in Supplementary Table S1 describe the FB sensor module, which senses the extracellular glucose concentration. The computer module corresponds to Equations (3.1-3.13), which contains transcription and translation of the crp and cyaA genes and cAMP production. The brake actuator module corresponds to Equations (4.1-4.13), which describes the role of the Mlc protein. Equations (5.1-5.26) show the accelerator actuator module, which contains the transcription and translation reactions of the ptsG, ptsH, ptsI, and crr genes.
###end p 15
###begin title 16
Dynamic simulation
###end title 16
###begin p 17
###xml 154 162 154 162 <xref ref-type="fig" rid="f3">Figure 3</xref>
###xml 249 258 249 258 <xref ref-type="fig" rid="f3">Figure 3A</xref>
###xml 284 287 284 287 <sup>Glc</sup>
###xml 355 358 355 358 <sup>Glc</sup>
###xml 511 520 511 520 <xref ref-type="fig" rid="f3">Figure 3B</xref>
###xml 687 690 687 690 <sup>Glc</sup>
###xml 875 884 875 884 <xref ref-type="fig" rid="f3">Figure 3C</xref>
###xml 949 953 949 953 <italic>ptsG</italic>
###xml 1047 1050 1047 1050 <sup>Glc</sup>
###xml 1121 1125 1121 1125 <italic>ptsG</italic>
###xml 1169 1173 1169 1173 <italic>ptsG</italic>
###xml 1200 1204 1200 1204 <italic>ptsH</italic>
###xml 1209 1213 1209 1213 <italic>ptsI</italic>
###xml 1289 1293 1289 1293 <italic>ptsH</italic>
###xml 1298 1302 1298 1302 <italic>ptsI</italic>
###xml 1338 1341 1338 1341 <sup>Glc</sup>
###xml 1355 1358 1355 1358 <sup>Glc</sup>
###xml 1421 1425 1421 1425 <italic>ptsG</italic>
###xml 1484 1493 1484 1493 <xref ref-type="fig" rid="f3">Figure 3D</xref>
###xml 1517 1521 1517 1521 <italic>ptsG</italic>
###xml 1523 1527 1523 1527 <italic>ptsH</italic>
###xml 1533 1537 1533 1537 <italic>ptsI</italic>
###xml 1857 1861 1857 1861 <italic>ptsG</italic>
###xml 1863 1867 1863 1867 <italic>ptsH</italic>
###xml 1873 1877 1873 1877 <italic>ptsI</italic>
###xml 2087 2090 2087 2090 <sup>Glc</sup>
To demonstrate how the mathematical model reproduces the dynamic behaviors of the glucose PTS with respect to glucose, we simulated the model as shown in Figure 3. These dynamic behaviors were very consistent with the experimental data. As shown in Figure 3A, the concentration of IIAGlc-P rapidly increased just after glucose depletion, while that of IIAGlc decreased. Since phosphorus is not transferred to glucose due to its depletion, the phosphorylated proteins accumulate in the plant module. As shown in Figure 3B, the concentration of cAMP greatly increased in response to glucose depletion and gradually decreased after the peak, then reached a steady-state. The accumulated IIAGlc-P protein, which is assumed to be the signal for adenylate cyclase activation, binds to adenylate cyclase in the FB sensor module, thereby enhancing the synthesis of cAMP. As shown in Figure 3C, the concentration of the complex of Mlc and promoter 1 for the ptsG gene increased in response to glucose depletion, which resulted from the decrease in the IICBGlc concentration. Consequently, the complex of Mlc and promoter 1 of the ptsG gene suppresses the gene expression of the ptsG gene. In the same manner, ptsH and ptsI gene expression was suppressed by the complex of Mlc and promoter 0 of the ptsH and ptsI genes. If the concentration of IICBGlc is high, IICBGlc captures Mlc to prevent Mlc from binding to promoter 1 of the ptsG gene, which permits transcription to proceed. As shown in Figure 3D, the expression of the ptsG, ptsH, and ptsI genes diminished in response to glucose depletion. This suppression was caused mainly by the brake actuator module. Actually, since the effect of the brake actuator module is greater than that of the accelerator actuator module in the absence of glucose, the synthesized Mlc protein suppresses the transcription of the ptsG, ptsH, and ptsI genes. The phosphotransfer activity decreases in the plant module, thereby decreasing glucose uptake. In the PTS, to solve the problem of glucose depletion, the signal of glucose depletion, the accumulated IIAGlc-P, is transferred to the signal transduction pathways to enhance other carbon transport systems.
###end p 17
###begin title 18
Validation of the mathematical model by experimental data
###end title 18
###begin p 19
###xml 163 171 163 171 <xref ref-type="fig" rid="f4">Figure 4</xref>
To further validate the mathematical model, we compared the simulated results with experimental data that were not used for the mathematical modeling, as shown in Figure 4. Such comparison of the simulated results with experimental data demonstrated that the dynamic behavior of the mathematical model was consistent with that of the experimental data.
###end p 19
###begin p 20
###xml 12 21 12 21 <xref ref-type="fig" rid="f4">Figure 4A</xref>
###xml 230 235 230 235 <italic>et al</italic>
###xml 216 241 216 241 <xref ref-type="bibr" rid="b32">Notley-McRobb <italic>et al</italic>, 1997</xref>
###xml 355 364 355 364 <xref ref-type="fig" rid="f4">Figure 4B</xref>
###xml 373 376 373 376 <sup>Glc</sup>
###xml 489 492 489 492 <sup>Glc</sup>
###xml 561 566 561 566 <italic>et al</italic>
###xml 554 572 554 572 <xref ref-type="bibr" rid="b14">Hogema <italic>et al</italic>, 1998</xref>
###xml 654 659 654 659 <italic>et al</italic>
###xml 643 666 643 666 <xref ref-type="bibr" rid="b54">Zeppenfeld <italic>et al</italic> (2000)</xref>
###xml 680 684 680 684 <italic>ptsG</italic>
###xml 723 726 723 726 <italic>mlc</italic>
###xml 744 747 744 747 <italic>mlc</italic>
###xml 747 748 747 748 <sup>&#8722;</sup>
###xml 758 762 758 762 <italic>lacZ</italic>
###xml 839 843 839 843 <italic>ptsG</italic>
###xml 1010 1014 1010 1014 <italic>ptsG</italic>
###xml 1039 1042 1039 1042 <italic>mlc</italic>
###xml 1042 1043 1042 1043 <sup>&#8722;</sup>
###xml 1113 1122 1113 1122 <xref ref-type="fig" rid="f4">Figure 4C</xref>
###xml 1146 1150 1146 1150 <italic>ptsG</italic>
###xml 1241 1245 1241 1245 <italic>ptsG</italic>
###xml 1300 1303 1300 1303 <italic>mlc</italic>
###xml 1357 1360 1357 1360 <italic>mlc</italic>
###xml 1360 1361 1360 1361 <sup>&#8722;</sup>
As shown in Figure 4A, the dynamic model reproduced the experimental behavior that the concentration of intracellular cAMP and CRP:cAMP varied with the extracellular glucose concentration in a dose-dependent manner (Notley-McRobb et al, 1997). The cAMP concentration in glucose-abundant medium was lower than that in glucose-deficient medium. As shown in Figure 4B, the IIAGlc protein was dephosphorylated at a high extracellular glucose concentration and the phosphorylation status of IIAGlc protein was responsible for the extracellular concentration (Hogema et al, 1998). These simulated results were consistent with the experimental data. Zeppenfeld et al (2000) measured the ptsG promoter activity in wild type and an mlc knockout strain (mlc-) using a lacZ fusion in minimum medium with glucose and glycerol. In wild-type cells, the ptsG promoter activity in glucose medium was higher than that in glycerol medium, which may result from the de-repression of Mlc. In both glycerol and glucose medium, the ptsG promoter activity in an mlc- knockout strain was higher than that in wild-type cells. As shown in Figure 4C, the expression of the ptsG gene was successfully reproduced by the simulation, where the glucose dose dependency for ptsG gene expression was observed both in wild type and an mlc knockout mutant and the gene expression level in the mlc- mutant was higher than that in wild-type cells regardless of the extracellular glucose concentration.
###end p 20
###begin title 21
Extraction of critical genes for enhanced glucose uptake
###end title 21
###begin p 22
###xml 63 71 63 71 <xref ref-type="fig" rid="f2">Figure 2</xref>
###xml 143 146 143 146 <italic>mlc</italic>
###xml 151 154 151 154 <italic>crp</italic>
###xml 246 249 246 249 <italic>mlc</italic>
###xml 299 302 299 302 <italic>mlc</italic>
###xml 374 377 374 377 <italic>crp</italic>
###xml 475 478 475 478 <italic>crp</italic>
###xml 556 560 556 560 <italic>ptsG</italic>
###xml 562 566 562 566 <italic>ptsH</italic>
###xml 568 572 568 572 <italic>ptsI</italic>
###xml 578 581 578 581 <italic>crr</italic>
###xml 837 841 837 841 <italic>ptsG</italic>
###xml 843 847 843 847 <italic>ptsH</italic>
###xml 849 853 849 853 <italic>ptsI</italic>
###xml 859 862 859 862 <italic>crr</italic>
###xml 912 915 912 915 <italic>mlc</italic>
###xml 1002 1005 1002 1005 <italic>crp</italic>
###xml 1027 1030 1027 1030 <italic>crp</italic>
The functional and flux module decomposition of the PTS model (Figure 2) readily provides a rational strategy for enhanced glucose uptake. The mlc and crp genes of the transcription regulation factors affect the expression of multiple genes. The mlc gene is responsible for the brake actuator, thus mlc knockout is expected to enhance the synthesis of the PTS proteins. The crp gene belongs to the computer module for the accelerator actuator, and thus overexpression of the crp gene has a potential to enhance the synthesis of the PTS proteins. Since the ptsG, ptsH, ptsI, and crr genes are the catalysts for the phosphorylation cascade in the plant module, it is reasonable to increase their expression for enhanced glucose uptake rates. It is critical for enhanced glucose uptake to increase the PTS proteins in the plant module (the ptsG, ptsH, ptsI, and crr genes), to delete the brake actuator module (the mlc gene), or to enhance the accelerator actuator module through the computer module (the crp gene). Regarding the crp gene manipulation it is necessary to consider the quantitative balance between the accelerator and brake flux modules, because CRP:cAMP not only enhances the accelerator actuator but also the brake actuator.
###end p 22
###begin title 23
Simulation and perturbation analysis of the rationally designed PTS
###end title 23
###begin p 24
###xml 135 138 135 138 <italic>crp</italic>
###xml 140 143 140 143 <italic>mlc</italic>
###xml 145 149 145 149 <italic>ptsG</italic>
###xml 151 155 151 155 <italic>ptsH</italic>
###xml 157 161 157 161 <italic>ptsI</italic>
###xml 167 170 167 170 <italic>crr</italic>
###xml 200 207 200 207 <xref ref-type="table" rid="t1">Table I</xref>
###xml 719 724 719 724 <italic>et al</italic>
###xml 707 730 707 730 <xref ref-type="bibr" rid="b3">Chassagnole <italic>et al</italic>, 2002</xref>
###xml 765 768 765 768 <italic>mlc</italic>
###xml 789 792 789 792 <italic>crp</italic>
###xml 813 816 813 816 <italic>crp</italic>
###xml 816 817 816 817 <sup>+</sup>
###xml 860 864 860 864 <italic>ptsI</italic>
###xml 974 977 974 977 <italic>mlc</italic>
###xml 1003 1006 1003 1006 <italic>crp</italic>
###xml 1033 1036 1033 1036 <italic>mlc</italic>
###xml 1076 1079 1076 1079 <italic>crp</italic>
###xml 1084 1088 1084 1088 <italic>ptsI</italic>
###xml 1304 1309 1304 1309 <italic>et al</italic>
###xml 1297 1315 1297 1315 <xref ref-type="bibr" rid="b14">Hogema <italic>et al</italic>, 1998</xref>
###xml 1335 1339 1335 1339 <italic>ptsI</italic>
###xml 1532 1536 1532 1536 <italic>ptsI</italic>
To further explore target genes critically responsible for enhancing glucose uptake, we performed perturbation analysis with regard to crp, mlc, ptsG, ptsH, ptsI, and crr gene expression, as shown in Table I, where the specific glucose uptake rates were simulated with respect to a 10-fold change in the copy number of these genes. When the concentration of a target gene was varied by 10-fold from the default condition (wild type), the ratio of the specific glucose uptake rate for a mathematical mutant to that for the wild type was simulated. The ratio of the phosphoenolpyruvate (PEP) concentration to the pyruvate (Pyr) concentration ([PEP]/[Pyr]) was set to 1 and each concentration was set to 1 mM (Chassagnole et al, 2002). We calculated the effect of the mlc gene disruption and crp gene amplification (crp+) on the specific glucose uptake rate. The ptsI gene amplification showed the most enhanced specific glucose uptake rate for all the strains: wild type, the mlc knockout mutant, and the crp-overexpressing mutant. An mlc knockout mutant that overexpressed the crp and ptsI genes was predicted to enhance the specific glucose uptake rate by the greatest degree. Since the ratio of the intracellular PEP to the Pyr concentration affected the specific glucose uptake rate by the PTS (Hogema et al, 1998), we simulated the ptsI amplification effect on an enhanced specific glucose uptake rate using various values of the ratio of [PEP]/[Pyr], by changing each molecule concentration from 0.1 to 10 mM and confirmed that ptsI amplification was always effective in enhancing the glucose uptake (data not shown). Based on this result, the subsequent simulations were performed with 1:1 ratio at 1 mM of PEP and Pyr concentration.
###end p 24
###begin p 25
###xml 72 76 72 76 <italic>ptsI</italic>
###xml 177 181 177 181 <italic>ptsI</italic>
###xml 205 213 205 213 <xref ref-type="fig" rid="f5">Figure 5</xref>
###xml 333 336 333 336 <sup>Glc</sup>
###xml 505 508 505 508 <sup>Glc</sup>
###xml 530 541 530 541 <xref ref-type="fig" rid="f5">Figure 5A&#8211;D</xref>
###xml 644 648 644 648 <italic>ptsI</italic>
###xml 819 822 819 822 <sup>Glc</sup>
###xml 857 861 857 861 <italic>ptsI</italic>
###xml 962 965 962 965 <sup>Glc</sup>
###xml 1036 1039 1036 1039 <sup>Glc</sup>
###xml 1136 1139 1136 1139 <sup>Glc</sup>
###xml 1263 1268 1263 1268 <italic>et al</italic>
###xml 1256 1274 1256 1274 <xref ref-type="bibr" rid="b14">Hogema <italic>et al</italic>, 1998</xref>
###xml 1289 1304 1289 1304 <xref ref-type="fig" rid="f5">Figure 5E and F</xref>
###xml 1532 1536 1532 1536 <italic>ptsG</italic>
###xml 1546 1549 1546 1549 <italic>pts</italic>
To analyze the mechanism of how the glucose uptake rate is increased by ptsI gene amplification, the PTS component concentrations were simulated with respect to a change in the ptsI gene dose, as shown in Figure 5. Since the specific glucose uptake rate is defined as the rate of the phosphotransfer reaction from phosphorylated IICBGlc to glucose per cell, that is, the production rate of glucose-6-phosphate (G6P), the glucose uptake rate is closely related to that for the phosphorylated status of IICBGlc protein. As shown in Figure 5A-D, the concentrations of phosphorylated proteins increased with an increase in the concentration of the ptsI gene. This simulated result suggests that the increase in the PTS flux is caused by an increase in the EI protein concentration. In the simulation, the phosphorylated IIAGlc protein becomes abundant when the ptsI gene is 10-fold amplified compared with the default condition. The phosphorylation status of the IIAGlc protein is known to depend on extracellular sugars and most of the IIAGlc proteins are unphosphorylated when glucose is used in the medium. The phosphorylation of the IIAGlc protein is suggested to be the signal for increasing the activity of adenylate cyclase that converts ATP into cAMP (Hogema et al, 1998). As shown in Figure 5E and F, the specific glucose uptake rate and the intracellular cAMP and CRP:cAMP complex concentrations increased with an increase in the EI concentration. The increase in the CRP:cAMP concentration activates the transcription of the ptsG gene and pts operon, subsequently increasing the specific glucose uptake rate.
###end p 25
###begin p 26
###xml 11 15 11 15 <italic>ptsG</italic>
###xml 17 21 17 21 <italic>ptsH</italic>
###xml 23 26 23 26 <italic>crr</italic>
###xml 32 36 32 36 <italic>ptsI</italic>
###xml 48 52 48 52 <italic>ptsI</italic>
###xml 246 250 246 250 <italic>ptsI</italic>
###xml 448 453 448 453 <italic>et al</italic>
###xml 441 459 441 459 <xref ref-type="bibr" rid="b51">Weigel <italic>et al</italic>, 1982</xref>
###xml 467 472 467 472 <italic>et al</italic>
###xml 461 478 461 478 <xref ref-type="bibr" rid="b34">Patel <italic>et al</italic>, 2006</xref>
###xml 618 622 618 622 <italic>ptsH</italic>
###xml 627 631 627 631 <italic>ptsI</italic>
###xml 657 661 657 661 <italic>ptsI</italic>
###xml 718 722 718 722 <italic>ptsH</italic>
###xml 736 762 736 762 <xref ref-type="bibr" rid="b6">De Reuse and Danchin, 1988</xref>
###xml 800 804 800 804 <italic>ptsI</italic>
###xml 894 898 894 898 <italic>ptsI</italic>
Out of the ptsG, ptsH, crr, and ptsI genes, the ptsI gene was selected for detailed analysis because its amplification enhanced the specific glucose uptake rate most strongly. In addition, some background information supports this selection. The ptsI gene encodes the EI protein, which catalyzes the phosphate transfer reaction from PEP to the EI protein. This reaction is suggested to be a rate-limiting step for glucose uptake in the PTS (Weigel et al, 1982; Patel et al, 2006), and the enhanced EI protein concentration is expected to lead to an increase in the glucose PTS flux. The transcriptional attenuation of ptsH and ptsI occurs and the amount of ptsI transcripts is suggested to be one-tenth of that of the ptsH transcripts (De Reuse and Danchin, 1988). Supposedly, the attenuation of the ptsI transcript is one of the intrinsic points governing the glucose PTS flux. Therefore, the ptsI gene was a reasonable choice among the enzymes of the phosphorylation cascade in the plant module.
###end p 26
###begin title 27
Experimental validation of rationally designed cells
###end title 27
###begin p 28
###xml 4 7 4 7 <italic>mlc</italic>
###xml 52 55 52 55 <italic>crp</italic>
###xml 60 64 60 64 <italic>ptsI</italic>
###xml 350 353 350 353 <italic>crp</italic>
###xml 392 395 392 395 <italic>crp</italic>
The mlc knockout mutant that overexpresses both the crp and ptsI genes was predicted to enhance the specific glucose uptake rate most strongly. To evaluate the validity of the presented strategy, we carried out biological experiments. Since CRP is one of the global regulators whose functions are not fully clear, unexpected effects may be caused by crp gene amplification. Thus, we excluded crp-overexpressing mutants.
###end p 28
###begin p 29
###xml 37 41 37 41 <italic>ptsI</italic>
###xml 125 129 125 129 <italic>ptsI</italic>
###xml 242 246 242 246 <italic>ptsI</italic>
###xml 409 413 409 413 <italic>ptsI</italic>
###xml 446 450 446 450 <italic>ptsI</italic>
###xml 669 677 669 677 <xref ref-type="table" rid="t2">Table II</xref>
###xml 770 774 770 774 <italic>ptsI</italic>
First, we investigated the effect of ptsI gene amplification. The simulation results suggest that more than 10 copies of the ptsI gene are required for the enhancement of specific glucose uptake; thus, a high-copy number plasmid was used for ptsI gene expression. The enhancement of EI protein expression was confirmed by SDS-polyacrylamide gel electrophoresis (data not shown). To test our prediction on the ptsI-amplified strain, MG1655/pUC118-ptsI, and a control strain, MG1655/pUC118, were cultivated in 20 ml of M9 glucose medium in a shaking incubator for 18 h. Growth, glucose uptake, specific glucose uptake, and extracellular cAMP concentration were measured (Table II). Regardless of the similar growth of both strains, the specific glucose uptake rate of the ptsI-amplified strain was significantly higher than that of the control strain. These experimental findings supported the prediction that an increased EI protein concentration enhances the specific glucose uptake rate under normal cell growth conditions.
###end p 29
###begin p 30
###xml 65 69 65 69 <italic>ptsI</italic>
###xml 193 201 193 201 <xref ref-type="fig" rid="f6">Figure 6</xref>
###xml 244 248 244 248 <italic>ptsI</italic>
###xml 280 284 280 284 <italic>ptsI</italic>
###xml 372 375 368 371 <sub>600</sub>
###xml 548 552 544 548 <italic>ptsI</italic>
###xml 765 770 761 766 <italic>et al</italic>
###xml 758 776 754 772 <xref ref-type="bibr" rid="b51">Weigel <italic>et al</italic>, 1982</xref>
###xml 784 789 780 785 <italic>et al</italic>
###xml 778 795 774 791 <xref ref-type="bibr" rid="b34">Patel <italic>et al</italic>, 2006</xref>
Second, we compared the specific glucose uptake rate between the ptsI-overexpressing strain and a control, using non-growing cells in minimum medium without thiamine required for JM109 growth (Figure 6). The specific glucose uptake rate of the ptsI-amplified strain, JM109/pUC118-ptsI, was higher than that of the control strain, JM109/pUC118. The observed growth (DeltaOD600) was less than 0.6 in both strains. Mainly, the incorporated glucose was converted into acetic acid or other organic acids (data not shown). This result indicates that the ptsI gene amplification enhances the specific glucose uptake rate. This is also supported by previous kinetic studies that the EI protein concentration is critical for increasing the phosphate flux in the PTS (Weigel et al, 1982; Patel et al, 2006).
###end p 30
###begin p 31
###xml 37 41 37 41 <italic>ptsI</italic>
###xml 68 71 68 71 <italic>mlc</italic>
###xml 165 169 165 169 <italic>ptsI</italic>
###xml 207 211 207 211 <italic>ptsI</italic>
###xml 392 400 392 400 <xref ref-type="table" rid="t2">Table II</xref>
###xml 422 426 422 426 <italic>ptsI</italic>
###xml 554 558 554 558 <italic>ptsI</italic>
###xml 652 659 652 659 <xref ref-type="table" rid="t1">Table I</xref>
###xml 702 706 702 706 <italic>ptsI</italic>
###xml 785 788 785 788 <italic>mlc</italic>
Third, we examined the effect of how ptsI gene amplification in the mlc knockout mutant derived from MG1655 (MG1655M) enhances the specific glucose uptake rate. The ptsI amplification strain, MG1655M/pUC118-ptsI, and a control strain, MG1655M/pUC118, were cultured in 20 ml of M9 glucose medium in a shaking incubator for 18 h. We compared the specific glucose uptake among the four strains (Table II). The MG1655M/pUC118-ptsI strain showed the highest specific glucose uptake even though it had the lowest growth. The next highest was the MG1655/pUC118-ptsI strain. The predictions for specific glucose uptake rates were validated by the experiments (Table I), demonstrating that amplification of the ptsI gene increases the specific glucose uptake rate and further enhances it in an mlc knockout mutant.
###end p 31
###begin title 32
Discrepancies between simulation and experiment
###end title 32
###begin p 33
###xml 63 67 63 67 <italic>ptsI</italic>
###xml 188 196 188 196 <xref ref-type="table" rid="t2">Table II</xref>
###xml 278 282 278 282 <italic>ptsI</italic>
###xml 352 359 352 359 <italic>In vivo</italic>
###xml 437 441 437 441 <italic>ptsI</italic>
###xml 529 534 529 534 <italic>et al</italic>
###xml 523 541 523 541 <xref ref-type="bibr" rid="b18">Inada <italic>et al</italic> (1996)</xref>
###xml 611 614 611 614 <sup>Glc</sup>
###xml 641 648 641 648 <italic>E. coli</italic>
###xml 717 720 717 720 <sup>Glc</sup>
###xml 831 836 831 836 <italic>et al</italic>
###xml 826 842 826 842 <xref ref-type="bibr" rid="b33">Park <italic>et al</italic>, 2006</xref>
###xml 641 648 <span type="species:ncbi:562">E. coli</span>
In the simulation, the intracellular cAMP concentration in the ptsI-amplified strain was higher than that in wild type, but this was not consistent with the experimental data, as shown in Table II. We measured the cAMP concentration in the medium. The cAMP concentration in the ptsI gene amplification strain was lower than that in the control strain. In vivo, the ATP level may decrease or adenylate cyclase may not be activated by the ptsI gene amplification. Thus, we investigated the discrepancy in cAMP concentration. Inada et al (1996) showed that the dephosphorylation activity for the phosphorylated IIAGlc protein was observed when E. coli was cultured with glucose. Recently, not only the phosphorylated IIAGlc protein but also other factors have been reported to be involved in the activation of adenylate cyclase (Park et al, 2006). These mechanisms may explain the reason why the cAMP concentration shows the discrepancy between the mathematical and biological models.
###end p 33
###begin p 34
###xml 167 176 167 176 <xref ref-type="table" rid="t3">Table III</xref>
###xml 178 179 178 179 <italic>Q</italic>
###xml 257 279 257 279 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 436 443 436 443 <xref ref-type="table" rid="t1">Table I</xref>
###xml 576 579 576 579 <sup>Glc</sup>
###xml 665 668 665 668 <sup>Glc</sup>
###xml 689 694 689 694 <italic>et al</italic>
###xml 682 700 682 700 <xref ref-type="bibr" rid="b42">Rohwer <italic>et al</italic>, 2000</xref>
###xml 802 806 802 806 <italic>ptsG</italic>
###xml 813 820 813 820 <xref ref-type="table" rid="t1">Table I</xref>
###xml 845 849 845 849 <italic>ptsG</italic>
###xml 950 959 950 959 <xref ref-type="table" rid="t3">Table III</xref>
Subsequently, we improved the glucose PTS model that the activation of adenylate cyclase does not occur in the presence of glucose and simulated the model as shown in Table III. Q[2] in Equation (3.4) was set to zero when glucose was present in the medium (Supplementary Table S1). In the improved model the cAMP concentration hardly decreased (data not shown), which was more consistent with experimental data than the previous model (Table I). Furthermore, the model improvement solved another discrepancy regarding the relationship between glucose uptake rates and the IICBGlc enhancement experiment. The glucose uptake rate was suggested to be increased by IICBGlc enhancement (Rohwer et al, 2000), while the glucose uptake rate was simulated to decrease with an increase in the copy number of the ptsG gene (Table I). By model improvement, ptsG gene amplification increased the glucose uptake, which was consistent with the experimental result (Table III).
###end p 34
###begin p 35
###xml 87 90 87 90 <sup>Glc</sup>
###xml 228 231 228 231 <sup>Glc</sup>
The simulation of the improved model suggests that the effect of the phosphorylated IIAGlc-activated adenylate cyclase is very limited in the presence of glucose; in other words, unknown factors other than the phosphorylated IIAGlc play an important role in controlling the computer module.
###end p 35
###begin title 36
Severe growth suppression
###end title 36
###begin p 37
###xml 101 104 101 104 <italic>mlc</italic>
###xml 104 105 104 105 <sup>&#8722;</sup>
###xml 173 177 173 177 <italic>ptsG</italic>
###xml 191 194 191 194 <italic>pts</italic>
###xml 203 219 203 219 <xref ref-type="bibr" rid="b35">Plumbridge, 1998</xref>
###xml 225 230 225 230 <italic>et al</italic>
###xml 221 236 221 236 <xref ref-type="bibr" rid="b22">Kim <italic>et al</italic>, 1999</xref>
###xml 245 250 245 250 <italic>et al</italic>
###xml 238 256 238 256 <xref ref-type="bibr" rid="b48">Tanaka <italic>et al</italic>, 1999</xref>
###xml 334 337 334 337 <italic>mlc</italic>
###xml 527 530 527 530 <italic>mlc</italic>
###xml 550 554 550 554 <italic>ptsI</italic>
The specific glucose uptake rate was suppressed by Mlc in the wild type, while it was retained in an mlc- knockout mutant. Mlc is reported to suppress the expression of the ptsG gene and the pts operon (Plumbridge, 1998; Kim et al, 1999; Tanaka et al, 1999), thereby governing glucose uptake. As the dynamic simulation predicted, the mlc knockout enhanced the specific glucose uptake rate through synthesis of the PTS components, but our experimental results showed unexpected severe growth suppression with the combination of mlc gene deletion with ptsI gene amplification.
###end p 37
###begin p 38
###xml 76 83 76 83 <italic>E. coli</italic>
###xml 92 97 92 97 <italic>et al</italic>
###xml 85 103 85 103 <xref ref-type="bibr" rid="b20">Kadner <italic>et al</italic>, 1992</xref>
###xml 147 151 147 151 <italic>ptsI</italic>
###xml 245 253 245 253 <xref ref-type="table" rid="t2">Table II</xref>
###xml 280 287 280 287 <italic>E. coli</italic>
###xml 382 386 382 386 <italic>ptsG</italic>
###xml 423 428 423 428 <italic>et al</italic>
###xml 416 434 416 434 <xref ref-type="bibr" rid="b29">Morita <italic>et al</italic>, 2003</xref>
###xml 455 462 455 462 <italic>E. coli</italic>
###xml 76 83 <span type="species:ncbi:562">E. coli</span>
###xml 280 287 <span type="species:ncbi:562">E. coli</span>
###xml 455 462 <span type="species:ncbi:562">E. coli</span>
It is known that the excess accumulation of G6P inhibits cellular growth in E. coli (Kadner et al, 1992). The growth suppression in MG1655M/pUC118-ptsI may be caused by the excess accumulation of sugar phosphate due to the rapid glucose uptake (Table II). Recently, small RNAs in E. coli have been shown to respond to an intracellular sugar concentration and the transcripts of the ptsG gene are degraded by RNaseE (Morita et al, 2003). We speculate that E. coli has some unknown severe control systems for the pool size of sugar phosphate and no activation of adenylate cyclase in glucose medium can be due to such control systems. A further refined and extended model including G6P metabolism will clarify the control mechanism of glucose uptake.
###end p 38
###begin title 39
Power of computer-aided rational design
###end title 39
###begin p 40
We have presented a general strategy for the rational design of biochemical networks for an engineering purpose. The strategy consists of constructing a biochemical network, dynamic simulation, module-based analysis, perturbation analysis, and experimental validation. CAD supports construction of a biochemical network map, building its dynamic model, and system analysis. Module-based analysis decomposes a biochemical network map into hierarchical modules, functional and flux modules, in a manner analogous to control engineering architectures. If an engineering purpose is determined, functional modules are readily determined and an engineering function is assigned to each module. This facilitates rational design of a genetic manipulation responsible for achieving the purpose and an intuitive understanding of how the biochemical network of interest can be improved or modified. Perturbation analysis further explores critical genes responsible for achieving the engineering purpose.
###end p 40
###begin p 41
###xml 284 288 284 288 <italic>ptsI</italic>
###xml 307 310 307 310 <italic>mlc</italic>
###xml 433 437 433 437 <italic>ptsI</italic>
###xml 454 457 454 457 <italic>mlc</italic>
Using CADLIVE we performed mathematical modeling, simulation, and system analysis to make a strategy of how the glucose PTS can be genetically engineered for enhanced glucose uptake. We found the critical factors responsible for an enhanced specific glucose uptake rate, for example, ptsI amplification and mlc knockout. Mathematical simulation and subsequent perturbation analysis predicted that the combination of amplification of ptsI and deletion of mlc would enhance the specific glucose uptake rate. Finally, experimental data validated this prediction.
###end p 41
###begin title 42
Rational design of a robust system
###end title 42
###begin p 43
###xml 552 556 552 556 <italic>ptsI</italic>
###xml 619 627 619 627 <xref ref-type="fig" rid="f5">Figure 5</xref>
###xml 633 636 633 636 <sup>Glc</sup>
###xml 720 724 720 724 <italic>ptsI</italic>
###xml 831 835 831 835 <italic>ptsI</italic>
###xml 901 904 901 904 <sup>Glc</sup>
###xml 975 979 975 979 <italic>ptsI</italic>
###xml 1172 1175 1172 1175 <italic>mlc</italic>
###xml 1199 1203 1199 1203 <italic>ptsI</italic>
Rational design requires an understanding of the mechanism of how a biochemical network provides a robust property to a target performance, or identifying the genes that show fragility of the performance to their genetic change. Manipulation for a particular flux module has a great potential to change the network performance of interest, for example, deletion of a negative FB loop or enhancement of a positive FB loop readily alters the cellular performance. In the glucose PTS, the brake actuator flux module has a negative FB loop. An increase in ptsI gene expression enhances phosphorylation of the PTS proteins (Figure 5), IIAGlc-P:CYA binding, CRP:cAMP synthesis, and Mlc production in turn, thereby suppressing ptsI gene expression. By contrast, the accelerator actuator flux module has a positive FB loop. An increase in ptsI gene expression enhances phosphorylation of the PTS proteins, IIAGlc-P:CYA binding, and CRP:cAMP synthesis in turn, which further enhances ptsI gene expression. Genetic manipulation for such a negative or positive FB loop shows a great potential to enhance the specific glucose uptake or activation of the PTS proteins. Knockout of the mlc gene is reasonable for ptsI gene overexpression, because it removes the negative FB loop that suppresses EI protein expression. Perturbation analysis in both the mathematical model and biological experiment support this design strategy.
###end p 43
###begin p 44
###xml 98 101 98 101 <sup>Glc</sup>
###xml 617 621 617 621 <italic>ptsI</italic>
###xml 625 629 625 629 <italic>ptsH</italic>
###xml 666 669 666 669 <italic>mlc</italic>
###xml 687 695 687 695 <xref ref-type="table" rid="t1">Tables I</xref>
###xml 700 703 700 703 <xref ref-type="table" rid="t3">III</xref>
In the improved model, positive and negative FBs were cancelled by disabling the function that IIAGlc-P:CYA synthesizes cAMP, where the glucose PTS system forms a more straight forward network. The brake flux module without the negative FB shows less suppression of PTS proteins with respect to EI or HPr overexpression, and the accelerator flux module without the positive FB weakens the expression of them. Actually, the specific glucose rate would be determined through the quantitative balance between the brake and accelerator modules. In the improved model, the decrease in the specific glucose uptake rate for ptsI or ptsH overexpression for wild type and an mlc knockout mutant (Tables I and III) would be due to deletion of the positive FB loop, while the increased uptake rates for other mutants would be caused by removal of the negative FB loop. It is of critical importance for rational design to understand the quantitative mechanism of how a flux module provides robustness to genetic changes.
###end p 44
###begin title 45
Toward a perfect design
###end title 45
###begin p 46
###xml 230 234 230 234 <italic>ptsI</italic>
###xml 253 256 253 256 <italic>mlc</italic>
###xml 449 453 449 453 <italic>ptsI</italic>
###xml 612 621 612 621 <xref ref-type="table" rid="t2">Tables II</xref>
###xml 626 629 626 629 <xref ref-type="table" rid="t3">III</xref>
###xml 660 663 660 663 <italic>mlc</italic>
###xml 663 664 663 664 <sup>&#8722;</sup>
###xml 724 733 724 733 <xref ref-type="table" rid="t2">Tables II</xref>
###xml 738 741 738 741 <xref ref-type="table" rid="t3">III</xref>
###xml 1063 1087 1063 1087 <xref ref-type="bibr" rid="b4">Curtis and Epstein, 1975</xref>
###xml 1108 1113 1108 1113 <italic>et al</italic>
###xml 1089 1119 1089 1119 <xref ref-type="bibr" rid="b13">Hernandez-Montalvo <italic>et al</italic>, 2003</xref>
The simulation results did not necessarily explain the experimental results. As mentioned above, there was a discrepancy in the change in the cAMP concentration between the mathematical and experimental models. The combination of ptsI amplification and mlc deficiency was predicted to be a better strategy for enhanced specific glucose uptake, but it led to severe growth inhibition. From the mathematical simulation of specific glucose uptake, the ptsI gene-overexpressing strain was predicted to have a ratio of 3.87 compared with control, but experimentally at best a ratio of 1.2 (0.018/0.015) was observed (Tables II and III). Likewise, the ratio for the mlc- background was 5.70, but experimentally 1.7 (0.026/0.015) (Tables II and III). These differences seem to be due to the insufficient model size or lack of various FB regulations of enzyme and gene expressions that provide robustness to genetic modifications in the actual cells. In addition the other proteins, mannose PTS and non-PTS transporter, GalP, which are involved in permeation of glucose (Curtis and Epstein, 1975; Hernandez-Montalvo et al, 2003), may affect the experimental results.
###end p 46
###begin p 47
The PEP/Pyr ratio is determined as a result of many enzymatic reactions including glycolysis, pentose-phosphate pathway, and anaplerotic pathways. Since growth is the output of complex interactions of a variety of molecules, it is still hard to accurately predict cell growth at the molecular interaction level. A large and complex model would be necessary that includes various regulations of enzyme and gene expressions in the glycolysis, pentose-phosphate pathway, TCA cycle, and anaplerotic pathway. An extended model is expected to clearly describe the experimental results.
###end p 47
###begin p 48
If some discrepancies are found between the mathematical and experimental models, we need to feed this information back into model improvement. Ideally we should iterate the process consisting of mathematical analysis and experimental validation until prediction agrees with experimental results completely. This iteration cycle is key to the rational design of biochemical systems.
###end p 48
###begin p 49
In conclusion, a computer-aided rational design approach was successfully applied to microbe engineering or breeding and verified by biological experiments. This methodology will lead to rapid development for not only applied biology that designs biochemical networks within a cell, but also fundamental research that reveals the mechanism of how biochemical networks generate particular cellular functions.
###end p 49
###begin title 50
Materials and methods
###end title 50
###begin title 51
Computer-aided rational design of biochemical networks
###end title 51
###begin p 52
###xml 353 361 353 361 <xref ref-type="fig" rid="f1">Figure 1</xref>
CAD is widely defined as computer-based tools that assist engineers, architects, and other design professionals in their design activities. CAD has been employed to conduct basic and applied research in drawing, modeling, simulation, and optimization of various engineering systems. The concept of CAD can be applied to biochemical systems, as shown in Figure 1. CAD supports not only constructing biochemical network maps but also mathematical modeling, simulation, and system analysis. To rationally design a biochemical network, it is important to present an engineering purpose and to decompose it into hierarchical functional and flux modules according to the purpose. In a manner analogous to control engineering architecture, a particular function is assigned to each functional module and mathematical simulation with perturbation analysis explores the genes critically responsible for achieving the purpose. These algorithms present a promising strategy for rational design of biochemical networks, providing instruction or prediction of how genes should be modified or manipulated. To validate the prediction, biological experiments are required. If there is any difference between the prediction and the experiment results, biochemical networks need to be redesigned through an understanding of the mechanisms that cause such discrepancies.
###end p 52
###begin title 53
Biological model
###end title 53
###begin p 54
###xml 100 105 100 105 <italic>et al</italic>
###xml 93 111 93 111 <xref ref-type="bibr" rid="b37">Postma <italic>et al</italic>, 1993</xref>
###xml 236 241 236 241 <italic>et al</italic>
###xml 229 247 229 247 <xref ref-type="bibr" rid="b38">Postma <italic>et al</italic>, 1996</xref>
###xml 269 276 269 276 <italic>E. coli</italic>
###xml 326 329 326 329 <sup>Glc</sup>
###xml 334 337 334 337 <sup>Glc</sup>
###xml 386 390 386 390 <italic>ptsG</italic>
###xml 392 395 392 395 <italic>crr</italic>
###xml 397 401 397 401 <italic>ptsH</italic>
###xml 407 411 407 411 <italic>ptsI</italic>
###xml 456 464 456 464 <xref ref-type="fig" rid="f2">Figure 2</xref>
###xml 490 495 490 495 <italic>et al</italic>
###xml 483 501 483 501 <xref ref-type="bibr" rid="b38">Postma <italic>et al</italic>, 1996</xref>
###xml 511 516 511 516 <italic>et al</italic>
###xml 504 523 504 523 <xref ref-type="bibr" rid="b42">Rohwer <italic>et al</italic> (2000)</xref>
###xml 269 276 <span type="species:ncbi:562">E. coli</span>
The PTS transports sugars from the periplasm to the cytoplasm, coupled with phosphorylation (Postma et al, 1993). The source of phosphate is PEP in the cytoplasm. The PTS relays the phosphate from PEP to sugars (for a review see Postma et al, 1996). The glucose PTS in E. coli has been studied intensively. It consists of IICBGlc, IIAGlc, HPr, and EI proteins, which are encoded by the ptsG, crr, ptsH, and ptsI genes, respectively (schematically shown in Figure 2; for a review see Postma et al, 1996). Rohwer et al (2000) measured the kinetic constants of the phosphotransfer reactions and made a kinetic model of the glucose PTS.
###end p 54
###begin p 55
###xml 0 7 0 7 <italic>E. coli</italic>
###xml 125 130 125 130 <italic>et al</italic>
###xml 118 136 118 136 <xref ref-type="bibr" rid="b15">Hogema <italic>et al</italic>, 1997</xref>
###xml 281 286 281 286 <italic>et al</italic>
###xml 277 292 277 292 <xref ref-type="bibr" rid="b26">Lux <italic>et al</italic>, 1995</xref>
###xml 301 306 301 306 <italic>et al</italic>
###xml 294 312 294 312 <xref ref-type="bibr" rid="b38">Postma <italic>et al</italic>, 1996</xref>
###xml 319 324 319 324 <italic>et al</italic>
###xml 314 330 314 330 <xref ref-type="bibr" rid="b46">Seok <italic>et al</italic>, 1997</xref>
###xml 332 343 332 343 <xref ref-type="bibr" rid="b43">Saier, 1998</xref>
###xml 352 357 352 357 <italic>et al</italic>
###xml 345 363 345 363 <xref ref-type="bibr" rid="b8">Eppler <italic>et al</italic>, 2002</xref>
###xml 573 576 573 576 <sup>Glc</sup>
###xml 626 651 626 651 <xref ref-type="bibr" rid="b40">Reddy and Kamireddi, 1998</xref>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli prefers glucose rather than other sugars for its growth and glucose represses the catabolism of other sugars (Hogema et al, 1997). The glucose PTS is related to catabolite repression, chemotaxis regulation, glycogen phosphorylase, and multiple regulatory interactions (Lux et al, 1995; Postma et al, 1996; Seok et al, 1997; Saier, 1998; Eppler et al, 2002). Adenylate cyclase is activated when glucose in the medium is depleted. Although the detailed mechanisms of this activation are still unclear, we assume the complex of adenylate cyclase and phosphorylated IIAGlc protein is the active form of adenylate cyclase (Reddy and Kamireddi, 1998).
###end p 55
###begin p 56
###xml 97 102 97 102 <italic>et al</italic>
###xml 90 108 90 108 <xref ref-type="bibr" rid="b38">Postma <italic>et al</italic>, 1996</xref>
###xml 115 119 115 119 <italic>ptsH</italic>
###xml 121 125 121 125 <italic>ptsI</italic>
###xml 131 134 131 134 <italic>crr</italic>
###xml 170 173 170 173 <italic>crr</italic>
###xml 211 216 211 216 <italic>et al</italic>
###xml 207 222 207 222 <xref ref-type="bibr" rid="b9">Fox <italic>et al</italic>, 1992</xref>
###xml 224 250 224 250 <xref ref-type="bibr" rid="b6">De Reuse and Danchin, 1988</xref>
###xml 371 387 371 387 <xref ref-type="bibr" rid="b36">Plumbridge, 2002</xref>
###xml 419 422 419 422 <sup>Glc</sup>
###xml 472 476 472 476 <italic>ptsG</italic>
###xml 478 482 478 482 <italic>ptsH</italic>
###xml 488 492 488 492 <italic>ptsI</italic>
###xml 524 529 524 529 <italic>et al</italic>
###xml 517 535 517 535 <xref ref-type="bibr" rid="b48">Tanaka <italic>et al</italic>, 1999</xref>
###xml 542 545 542 545 <italic>mlc</italic>
###xml 657 662 657 662 <italic>et al</italic>
###xml 650 668 650 668 <xref ref-type="bibr" rid="b7">Decker <italic>et al</italic>, 1998</xref>
###xml 675 680 675 680 <italic>et al</italic>
###xml 670 686 670 686 <xref ref-type="bibr" rid="b47">Shin <italic>et al</italic>, 2001</xref>
###xml 707 710 707 710 <italic>fis</italic>
###xml 770 777 770 777 <italic>E. coli</italic>
###xml 784 789 784 789 <italic>et al</italic>
###xml 779 795 779 795 <xref ref-type="bibr" rid="b2">Ball <italic>et al</italic>, 1992</xref>
###xml 807 812 807 812 <italic>et al</italic>
###xml 797 818 797 818 <xref ref-type="bibr" rid="b31">Ninnemann <italic>et al</italic>, 1992</xref>
###xml 826 831 826 831 <italic>et al</italic>
###xml 820 837 820 837 <xref ref-type="bibr" rid="b39">Pratt <italic>et al</italic>, 1997</xref>
###xml 846 851 846 851 <italic>et al</italic>
###xml 839 857 839 857 <xref ref-type="bibr" rid="b50">Walker <italic>et al</italic>, 1999</xref>
###xml 866 871 866 871 <italic>et al</italic>
###xml 859 877 859 877 <xref ref-type="bibr" rid="b30">Nasser <italic>et al</italic>, 2001</xref>
###xml 886 891 886 891 <italic>et al</italic>
###xml 879 897 879 897 <xref ref-type="bibr" rid="b27">Mallik <italic>et al</italic>, 2004</xref>
###xml 904 907 904 907 <italic>fis</italic>
###xml 1018 1022 1018 1022 <italic>ptsG</italic>
###xml 1032 1035 1032 1035 <italic>pts</italic>
###xml 1094 1099 1094 1099 <italic>et al</italic>
###xml 1090 1105 1090 1105 <xref ref-type="bibr" rid="b9">Fox <italic>et al</italic>, 1992</xref>
###xml 1107 1133 1107 1133 <xref ref-type="bibr" rid="b6">De Reuse and Danchin, 1988</xref>
###xml 1135 1151 1135 1151 <xref ref-type="bibr" rid="b35">Plumbridge, 1998</xref>
###xml 1157 1162 1157 1162 <italic>et al</italic>
###xml 1153 1168 1153 1168 <xref ref-type="bibr" rid="b22">Kim <italic>et al</italic>, 1999</xref>
###xml 1177 1182 1177 1182 <italic>et al</italic>
###xml 1170 1188 1170 1188 <xref ref-type="bibr" rid="b48">Tanaka <italic>et al</italic>, 1999</xref>
###xml 1213 1216 1213 1216 <italic>crp</italic>
###xml 1311 1334 1311 1334 <xref ref-type="bibr" rid="b11">Hanamura and Aiba, 1991</xref>
###xml 1336 1340 1336 1340 <xref ref-type="bibr" rid="b12">1992</xref>
###xml 1351 1356 1351 1356 <italic>et al</italic>
###xml 1342 1362 1342 1362 <xref ref-type="bibr" rid="b19">Ishizuka <italic>et al</italic>, 1994</xref>
###xml 770 777 <span type="species:ncbi:562">E. coli</span>
The gene expression regulation of the glucose PTS has been investigated (for a review see Postma et al, 1996). The ptsH, ptsI, and crr genes form an operon; however, the crr gene possesses its own promoter (Fox et al, 1992; De Reuse and Danchin, 1988). The global transcriptional regulators, CRP, Mlc, and Fis, play important roles in gene expression of the glucose PTS (Plumbridge, 2002). Mlc is able to bind both IICBGlc protein and DNA, and regulates expression of the ptsG, ptsH, and ptsI genes and its own gene (Tanaka et al, 1999). The mlc gene possesses two promoters and they are both positively and negatively regulated by Mlc and CRP:cAMP (Decker et al, 1998; Shin et al, 2001). The regulation of fis gene expression is complex and is related to the growth of E. coli (Ball et al, 1992; Ninnemann et al, 1992; Pratt et al, 1997; Walker et al, 1999; Nasser et al, 2001; Mallik et al, 2004). The fis gene is excluded from the mathematical model for simplification. Basically, CRP:cAMP positively regulates the ptsG gene and pts operon expression, and Mlc negatively regulates them (Fox et al, 1992; De Reuse and Danchin, 1988; Plumbridge, 1998; Kim et al, 1999; Tanaka et al, 1999). The expression of the crp gene, which encodes the CRP protein, is regulated both positively and negatively by CRP:cAMP (Hanamura and Aiba, 1991, 1992; Ishizuka et al, 1994).
###end p 56
###begin p 57
###xml 83 87 83 87 <italic>cyaA</italic>
###xml 94 98 94 98 <italic>cyaA</italic>
###xml 152 162 152 162 <xref ref-type="bibr" rid="b1">Aiba, 1985</xref>
###xml 170 175 170 175 <italic>et al</italic>
###xml 164 181 164 181 <xref ref-type="bibr" rid="b18">Inada <italic>et al</italic>, 1996</xref>
###xml 270 292 270 292 <xref ref-type="bibr" rid="b53">Yang and Epstein, 1983</xref>
###xml 379 383 379 383 <italic>cpdA</italic>
###xml 398 403 398 403 <italic>et al</italic>
###xml 390 409 390 409 <xref ref-type="bibr" rid="b17">Imamura <italic>et al</italic>, 1996</xref>
###xml 440 465 440 465 <xref ref-type="bibr" rid="b10">Goldenbaum and Hall, 1979</xref>
###xml 564 586 564 586 <xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>
###xml 796 801 794 799 <italic>et al</italic>
###xml 788 807 786 805 <xref ref-type="bibr" rid="b21">Keseler <italic>et al</italic>, 2005</xref>
Adenylate cyclase catalyzes the reaction from ATP to cAMP and it is encoded by the cyaA gene. cyaA gene expression is negatively regulated by CRP:cAMP (Aiba, 1985; Inada et al, 1996). The adenylate cyclase reaction is considered to follow the Michaelis-Menten equation (Yang and Epstein, 1983). Intracellular cAMP is degraded to AMP by phosphodiesterase, which is encoded by the cpdA gene (Imamura et al, 1996), or is excreted into medium (Goldenbaum and Hall, 1979). The degradation and excretion of cAMP is assumed to follow a linear equation (Equation (3.4) in Supplementary Table S1). For simplification, only cAMP+CRP --> CRP:cAMP is considered for the pathway of CRP:cAMP complex formation. The numbers of binding sites for CRP:cAMP on the whole genome were estimated using EcoCyc (Keseler et al, 2005).
###end p 57
###begin title 58
Mathematical model
###end title 58
###begin p 59
###xml 99 106 99 106 <italic>E. coli</italic>
###xml 127 157 127 157 <xref ref-type="supplementary-material" rid="S1">Supplementary Tables S1 and S2</xref>
###xml 181 186 181 186 <italic>et al</italic>
###xml 174 192 174 192 <xref ref-type="bibr" rid="b24">Kurata <italic>et al</italic>, 2005</xref>
###xml 1031 1036 1031 1036 <italic>et al</italic>
###xml 1019 1043 1019 1043 <xref ref-type="bibr" rid="b3">Chassagnole <italic>et al</italic> (2002)</xref>
###xml 99 106 <span type="species:ncbi:562">E. coli</span>
Based on the molecular interactions described above, we built a detailed mathematical model of the E. coli glucose PTS system (Supplementary Tables S1 and S2) using CADLIVE (Kurata et al, 2005). The CADLIVE system possesses a graphical user interface for inputting the biological process, building up mathematical equations, and system analysis. In the model, the mathematical formula consisted of 44 algebraic equations and 19 differential equations with 131 parameters. The model uses first-order mass action kinetics to describe the synthesis, proteolysis, and binding of proteins. We make the common assumption that binding reactions occur on a faster time scale than production and degradation of proteins. Therefore, we replace the differential equations describing these fast binding reactions by algebraic equations. The kinetic parameters for the PTS model were picked or estimated from existing PTS-related literature. The intracellular metabolite concentrations were set to a constant based on the data from Chassagnole et al (2002).
###end p 59
###begin title 60
Module decomposition analogous to control engineering
###end title 60
###begin p 61
###xml 195 200 195 200 <italic>et al</italic>
###xml 188 206 188 206 <xref ref-type="bibr" rid="b25">Kurata <italic>et al</italic>, 2003</xref>
###xml 208 212 208 212 <xref ref-type="bibr" rid="b23">2006</xref>
A module has been characterized as a subsystem that possesses a function that is separable from that of other modules, in the sense that it is capable of maintaining most of its identity (Kurata et al, 2003, 2006). To provide a useful characterization of modularity, a multi-resolution scheme can then be used to assess different aspects of the modular decomposition, zooming out from the molecular description (molecular modules) to a block diagram-like picture (functional modules). At a lower level of resolution, the components of a system can be divided into functional groups that we refer to as functional modules. We sought analogies with the modules that are traditionally identified in control engineering schemes. The process to be controlled is identified and the rest of the network is classified in terms of the function that it accomplishes to facilitate this regulation. A block represents each of these modules and the interconnection of such blocks is frequently referred to as a block diagram. We define a flux module as a pathway that traces the mechanisms of interaction of a group of molecules involved together in the performance of a certain function. A flux module ideally connects functional modules, but forms an entity that possesses its own functionality. Therefore, a flux is essentially the flow of information in the network.
###end p 61
###begin title 62
Strains and plasmids
###end title 62
###begin p 63
###xml 62 70 62 70 <xref ref-type="table" rid="t4">Table IV</xref>
###xml 72 79 72 79 <italic>E. coli</italic>
###xml 87 90 87 90 <italic>mlc</italic>
###xml 90 91 90 91 <sup>&#8722;</sup>
###xml 135 161 135 161 <xref ref-type="bibr" rid="b5">Datsenko and Wanner (2000)</xref>
###xml 72 79 <span type="species:ncbi:562">E. coli</span>
The strains and plasmids used in this study are summarized in Table IV. E. coli MG1655 mlc- was constructed according to the method of Datsenko and Wanner (2000).
###end p 63
###begin p 64
###xml 208 211 208 211 <italic>cat</italic>
###xml 228 232 228 232 <italic>ptsI</italic>
###xml 270 273 270 273 <italic>pts</italic>
###xml 324 329 324 329 <italic>et al</italic>
###xml 320 335 320 335 <xref ref-type="bibr" rid="b9">Fox <italic>et al</italic>, 1992</xref>
###xml 337 363 337 363 <xref ref-type="bibr" rid="b6">De Reuse and Danchin, 1988</xref>
###xml 426 430 426 430 <italic>phoC</italic>
###xml 436 455 436 455 <italic>Morganella morganii</italic>
###xml 468 472 468 472 <italic>ptsI</italic>
###xml 492 499 492 499 <italic>E. coli</italic>
###xml 536 541 536 541 <italic>et al</italic>
###xml 529 547 529 547 <xref ref-type="bibr" rid="b28">Mihara <italic>et al</italic>, 2000</xref>
###xml 569 576 569 576 <italic>E. coli</italic>
###xml 616 620 616 620 <italic>ptsI</italic>
###xml 208 211 <span type="species:ncbi:9685">cat</span>
###xml 436 455 <span type="species:ncbi:582">Morganella morganii</span>
###xml 492 499 <span type="species:ncbi:562">E. coli</span>
###xml 569 576 <span type="species:ncbi:562">E. coli</span>
Briefly, 5'-AGAACCGTTATACATCGCGTCTTTTACCAGTGCAGCTGAAGCCTGCTTTTTTAT-3' and 5'-TCTGCGCATTAGTCGCGGGGAGATTTTCCTTGCTCTCGCTCAAGTTAGTATAAA-3' were used as PCR primers. The amplified fragment was used to replace the cat gene. Since the ptsI gene is located in the middle of the pts operon, it does not possess its own promoter (Fox et al, 1992; De Reuse and Danchin, 1988). We used the promoter sequence of the acid phosphatase gene, phoC from Morganella morganii, for stable ptsI gene expression in E. coli, with glucose in the medium (Mihara et al, 2000). Plasmid pUC118 and E. coli strain JM109 were used for cloning the ptsI gene.
###end p 64
###begin p 65
###xml 4 8 4 8 <italic>ptsI</italic>
###xml 303 306 303 306 <italic>Pst</italic>
###xml 312 315 312 315 <italic>Hin</italic>
###xml 363 366 363 366 <italic>Bam</italic>
###xml 373 376 373 376 <italic>Pst</italic>
###xml 434 437 434 437 <italic>Bam</italic>
###xml 444 447 444 447 <italic>Hin</italic>
###xml 509 516 509 516 <italic>E. coli</italic>
###xml 509 516 <span type="species:ncbi:562">E. coli</span>
For ptsI gene amplification, 5'-GCCTGCAGCCGTAAGGAGGAATGTAGATGATTTCGAGCATT-3' and 5'-GCAAGCTTCTCGTGGATTAGCAG-3' were used as PCR primers. As a promoter sequence, 5'-GCGGATCCATTTTTTCAATGTGATTTTAACTTTTACTTACAGATGAC TATAATGTGACTAAAAACAAAACCATTGTTCTGGACATCTGCAGCG-3' was used. PCR products were treated with PstI and HindIII and the promoter sequence was treated with BamHI and PstI. After the ligation reaction using pUC118 digested with BamHI and HindIII and these fragments, the products were used to transform E. coli JM109.
###end p 65
###begin title 66
Culture condition
###end title 66
###begin p 67
###xml 68 73 68 73 <italic>et al</italic>
###xml 59 79 59 79 <xref ref-type="bibr" rid="b44">Sambrook <italic>et al</italic>, 1989</xref>
###xml 114 115 114 115 <sub>4</sub>
###xml 128 129 128 129 <sub>4</sub>
###xml 132 133 132 133 <sub>2</sub>
###xml 147 148 147 148 <sub>4</sub>
###xml 158 159 158 159 <sub>2</sub>
###xml 161 162 161 162 <sub>4</sub>
###xml 176 177 176 177 <sub>2</sub>
###xml 191 192 191 192 <sub>4</sub>
###xml 195 196 195 196 <sub>2</sub>
###xml 211 212 211 212 <sub>4</sub>
###xml 215 216 215 216 <sub>2</sub>
Cells were grown in L-broth, M9 medium with 20 mM glucose (Sambrook et al, 1989), or EI medium containing 20 mM NH4Cl, 2 mM MgSO4.7H2O, 40 mM NaHPO4, 30 mM KH2PO4, 0.01 mM CaCl2, 0.01 mM FeSO4.7H2O, 0.01 mM MnSO4.5H2O, 5 mM citrate, 50 mM MES-NaOH (pH 6.8), and 20 mM glucose. Cultivation was carried out at 37degreesC using a shaking incubator.
###end p 67
###begin title 68
Analysis
###end title 68
###begin p 69
For glucose uptake assay with non-growing cells, cells were collected from 50 ml of overnight culture grown in L-broth, and then washed and inoculated into 50 ml of M9-glucose medium and shaken at 37degreesC, aerobically. For the glucose uptake assay with growing cells, cells were collected from 1 ml of overnight culture grown in L-broth, and then washed and inoculated into 20 ml of M9-glucose medium and shaken at 37degreesC for 18 h under aerobic conditions. Into each culture, ampicillin (100 mug/ml) was added as required.
###end p 69
###begin p 70
The cAMP concentration was measured using a cAMP competitive ELISA kit (ENDOGEN, USA).
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin p 72
Supplementary Table S1
###end p 72
###begin p 73
Supplementary Table S2
###end p 73
###begin p 74
Supplementary Information
###end p 74
###begin p 75
Supplementary Information
###end p 75
###begin p 76
We thank Akira Imaizumi, Shintaro Iwatani, Yohei Yamada, and Takayuki Tanaka for invaluable discussions. We also thank Hiroyuki Aoyagi and Fumiko Yamamoto for excellent technical support.
###end p 76
###begin article-title 77
###xml 21 37 21 37 <italic>Escherichia coli</italic>
###xml 21 37 <span type="species:ncbi:562">Escherichia coli</span>
Transcription of the Escherichia coli adenylate cyclase gene is negatively regulated by cAMP-cAMP receptor protein.
###end article-title 77
###begin article-title 78
###xml 56 72 56 72 <italic>Escherichia coli</italic>
###xml 56 72 <span type="species:ncbi:562">Escherichia coli</span>
Dramatic changes in Fis levels upon nutrient upshift in Escherichia coli.
###end article-title 78
###begin article-title 79
###xml 53 69 53 69 <italic>Escherichia coli</italic>
###xml 53 69 <span type="species:ncbi:562">Escherichia coli</span>
Dynamic modeling of the central carbon metabolism of Escherichia coli.
###end article-title 79
###begin article-title 80
###xml 19 20 19 20 <sc>D</sc>
###xml 32 48 32 48 <italic>Escherichia coli</italic>
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
Phosphorylation of D-glucose in Escherichia coli mutants defective in glucosephosphotransferase, mannosephosphotransferase, and glucokinase.
###end article-title 80
###begin article-title 81
###xml 46 62 46 62 <italic>Escherichia coli</italic>
###xml 46 67 <span type="species:ncbi:83333">Escherichia coli K-12</span>
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
###end article-title 81
###begin article-title 82
###xml 4 8 4 8 <italic>ptsH</italic>
###xml 10 14 10 14 <italic>ptsI</italic>
###xml 20 23 20 23 <italic>crr</italic>
###xml 37 53 37 53 <italic>Escherichia coli</italic>
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
The ptsH, ptsI, and crr genes of the Escherichia coli phosphoenolpyruvate-dependent phosphotransferase system: a complex operon with several modes of transcription.
###end article-title 82
###begin article-title 83
###xml 79 83 79 83 <italic>malT</italic>
###xml 150 166 150 166 <italic>Escherichia coli</italic>
###xml 150 166 <span type="species:ncbi:562">Escherichia coli</span>
Negative transcriptional regulation of a positive regulator: the expression of malT, encoding the transcriptional activator of the maltose regulon of Escherichia coli, is negatively controlled by Mlc.
###end article-title 83
###begin article-title 84
###xml 54 70 54 70 <italic>Escherichia coli</italic>
###xml 54 70 <span type="species:ncbi:562">Escherichia coli</span>
Glycerol-3-phosphate-induced catabolite repression in Escherichia coli.
###end article-title 84
###begin article-title 85
###xml 43 46 43 46 <italic>pts</italic>
Evidence for two promoters upstream of the pts operon: regulation by the cAMP receptor protein regulatory complex.
###end article-title 85
###begin article-title 86
###xml 57 73 57 73 <italic>Escherichia coli</italic>
###xml 57 73 <span type="species:ncbi:562">Escherichia coli</span>
Transport of cyclic adenosine 3',5'-monophosphate across Escherichia coli vesicle membranes.
###end article-title 86
###begin article-title 87
###xml 50 70 50 70 <italic>Escherichia coli crp</italic>
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
Molecular mechanism of negative autoregulation of Escherichia coli crp gene.
###end article-title 87
###begin article-title 88
###xml 47 67 47 67 <italic>Escherichia coli crp</italic>
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
A new aspect of transcriptional control of the Escherichia coli crp gene: positive autoregulation.
###end article-title 88
###begin article-title 89
###xml 14 18 14 18 <italic>galP</italic>
###xml 23 26 23 26 <italic>glk</italic>
###xml 32 48 32 48 <italic>Escherichia coli</italic>
###xml 32 48 <span type="species:ncbi:562">Escherichia coli</span>
Expression of galP and glk in a Escherichia coli PTS mutant restores glucose transport and increases glycolytic flux to fermentation products.
###end article-title 89
###begin article-title 90
###xml 21 37 21 37 <italic>Escherichia coli</italic>
###xml 153 156 153 156 <sup>Glc</sup>
###xml 21 37 <span type="species:ncbi:562">Escherichia coli</span>
Inducer exclusion in Escherichia coli by non-PTS substrates: the role of the PEP to pyruvate ratio in determining the phosphorylation state of enzyme IIAGlc.
###end article-title 90
###begin article-title 91
###xml 71 87 71 87 <italic>Escherichia coli</italic>
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
Catabolite repression by glucose 6-phosphate, gluconate and lactose in Escherichia coli.
###end article-title 91
###begin article-title 92
Amino acid production processes.
###end article-title 92
###begin article-title 93
###xml 22 26 22 26 <italic>cpdA</italic>
###xml 99 115 99 115 <italic>Escherichia coli</italic>
###xml 99 115 <span type="species:ncbi:562">Escherichia coli</span>
Identification of the cpdA gene encoding cyclic 3',5'-adenosine monophosphate phosphodiesterase in Escherichia coli.
###end article-title 93
###begin article-title 94
###xml 62 78 62 78 <italic>Escherichia coli</italic>
###xml 62 78 <span type="species:ncbi:562">Escherichia coli</span>
Downregulation of cAMP production by cAMP receptor protein in Escherichia coli: an assessment of the contributions of transcriptional and posttranscriptional control of adenylate cyclase.
###end article-title 94
###begin article-title 95
###xml 72 88 72 88 <italic>Escherichia coli</italic>
###xml 120 123 120 123 <italic>crp</italic>
###xml 72 88 <span type="species:ncbi:562">Escherichia coli</span>
Mechanism of the down-regulation of cAMP receptor protein by glucose in Escherichia coli: role of autoregulation of the crp gene.
###end article-title 95
###begin article-title 96
###xml 82 98 82 98 <italic>Escherichia coli</italic>
###xml 82 98 <span type="species:ncbi:562">Escherichia coli</span>
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli.
###end article-title 96
###begin article-title 97
###xml 46 62 46 62 <italic>Escherichia coli</italic>
###xml 46 62 <span type="species:ncbi:562">Escherichia coli</span>
EcoCyc: a comprehensive database resource for Escherichia coli.
###end article-title 97
###begin article-title 98
###xml 55 58 55 58 <italic>pts</italic>
###xml 73 89 73 89 <italic>Escherichia coli</italic>
###xml 73 89 <span type="species:ncbi:562">Escherichia coli</span>
Purification of Mlc and analysis of its effects on the pts expression in Escherichia coli.
###end article-title 98
###begin article-title 99
Module-based analysis of robustness tradeoffs in the heat shock response system.
###end article-title 99
###begin article-title 100
CADLIVE dynamic simulator: direct link of biochemical networks to dynamic models.
###end article-title 100
###begin article-title 101
###xml 122 127 <span type="species:ncbi:4932">yeast</span>
CADLIVE for constructing a large-scale biochemical network based on a simulation-directed notation and its application to yeast cell cycle.
###end article-title 101
###begin article-title 102
###xml 126 142 126 142 <italic>Escherichia coli</italic>
###xml 126 142 <span type="species:ncbi:562">Escherichia coli</span>
Coupling the phosphotransferase system and the methyl-accepting chemotaxis protein-dependent chemotaxis signaling pathways of Escherichia coli.
###end article-title 102
###begin article-title 103
###xml 59 62 59 62 <italic>fis</italic>
###xml 138 141 138 141 <italic>fis</italic>
###xml 148 164 148 164 <italic>Escherichia coli</italic>
###xml 148 164 <span type="species:ncbi:562">Escherichia coli</span>
Growth phase-dependent regulation and stringent control of fis are conserved processes in enteric bacteria and involve a single promoter (fis P) in Escherichia coli.
###end article-title 103
###begin article-title 104
###xml 68 87 68 87 <italic>Morganella morganii</italic>
###xml 68 87 <span type="species:ncbi:582">Morganella morganii</span>
Phosphorylation of nucleosides by the mutated acid phosphatase from Morganella morganii.
###end article-title 104
###begin article-title 105
###xml 126 142 126 142 <italic>Escherichia coli</italic>
###xml 126 142 <span type="species:ncbi:562">Escherichia coli</span>
Accumulation of glucose 6-phosphate or fructose 6-phosphate is responsible for destabilization of glucose transporter mRNA in Escherichia coli.
###end article-title 105
###begin article-title 106
###xml 14 17 14 17 <italic>fis</italic>
CRP modulates fis transcription by alternate formation of activating and repressing nucleoprotein complexes.
###end article-title 106
###begin article-title 107
###xml 4 15 4 15 <italic>E. coli fis</italic>
###xml 4 11 <span type="species:ncbi:562">E. coli</span>
The E. coli fis promoter is subject to stringent control and autoregulation.
###end article-title 107
###begin article-title 108
###xml 79 95 79 95 <italic>Escherichia coli</italic>
###xml 79 95 <span type="species:ncbi:562">Escherichia coli</span>
The relationship between external glucose concentration and cAMP levels inside Escherichia coli: implications for models of phosphotransferase-mediated regulation of adenylate cyclase.
###end article-title 108
###begin article-title 109
###xml 0 8 0 8 <italic>In vitro</italic>
###xml 52 68 52 68 <italic>Escherichia coli</italic>
###xml 52 68 <span type="species:ncbi:562">Escherichia coli</span>
In vitro reconstitution of catabolite repression in Escherichia coli.
###end article-title 109
###begin article-title 110
###xml 48 64 48 64 <italic>Escherichia coli</italic>
###xml 48 64 <span type="species:ncbi:562">Escherichia coli</span>
The monomer/dimer transition of enzyme I of the Escherichia coli phosphotransferase system.
###end article-title 110
###begin article-title 111
###xml 14 18 14 18 <italic>ptsG</italic>
###xml 70 86 70 86 <italic>Escherichia coli</italic>
###xml 70 86 <span type="species:ncbi:562">Escherichia coli</span>
Expression of ptsG, the gene for the major glucose PTS transporter in Escherichia coli, is repressed by Mlc and induced by growth on glucose.
###end article-title 111
###begin article-title 112
###xml 44 60 44 60 <italic>Escherichia coli</italic>
###xml 44 60 <span type="species:ncbi:562">Escherichia coli</span>
Regulation of gene expression in the PTS in Escherichia coli: the role and interactions of Mlc.
###end article-title 112
###begin article-title 113
Phosphoenolpyruvate: carbohydrate phosphotransferase systems of bacteria.
###end article-title 113
###begin article-title 114
Phosphoenolpyruvate; carbohydrate phosphotransferase systems. In
###end article-title 114
###begin article-title 115
###xml 25 28 25 28 <italic>fis</italic>
###xml 48 64 48 64 <italic>Escherichia coli</italic>
###xml 48 64 <span type="species:ncbi:562">Escherichia coli</span>
Deletion analysis of the fis promoter region in Escherichia coli: antagonistic effects of integration host factor and Fis.
###end article-title 115
###begin article-title 116
###xml 14 30 14 30 <italic>Escherichia coli</italic>
###xml 14 30 <span type="species:ncbi:562">Escherichia coli</span>
Modulation of Escherichia coli adenylyl cyclase activity by catalytic-site mutants of protein IIA(Glc) of the phosphoenolpyruvate: sugar phosphotransferase system.
###end article-title 116
###begin article-title 117
###xml 101 117 101 117 <italic>Escherichia coli</italic>
###xml 101 117 <span type="species:ncbi:562">Escherichia coli</span>
Spatial stochastic modeling of the phosphoenolpyruvate-dependent phosphotransferase (PTS) pathway in Escherichia coli.
###end article-title 117
###begin article-title 118
###xml 140 148 140 148 <italic>in vitro</italic>
Understanding glucose transport by the bacterial phosphoenolpyruvate:glycose phosphotransferase system on the basis of kinetic measurements in vitro.
###end article-title 118
###begin article-title 119
Multiple mechanisms controlling carbon metabolism in bacteria.
###end article-title 119
###begin article-title 120
###xml 72 88 72 88 <italic>Escherichia coli</italic>
###xml 72 88 <span type="species:ncbi:562">Escherichia coli</span>
Modeling and experimental validation of the signal transduction via the Escherichia coli sucrose phosphotransferase system.
###end article-title 120
###begin article-title 121
###xml 51 67 51 67 <italic>Escherichia coli</italic>
###xml 51 67 <span type="species:ncbi:562">Escherichia coli</span>
High affinity binding and allosteric regulation of Escherichia coli glycogen phosphorylase by the histidine phosphocarrier protein, HPr.
###end article-title 121
###begin article-title 122
###xml 76 79 76 79 <italic>mlc</italic>
###xml 139 155 139 155 <italic>Escherichia coli</italic>
###xml 139 155 <span type="species:ncbi:562">Escherichia coli</span>
Heat shock RNA polymerase (E sigma(32)) is involved in the transcription of mlc and crucial for induction of the Mlc regulon by glucose in Escherichia coli.
###end article-title 122
###begin article-title 123
###xml 27 30 27 30 <italic>pts</italic>
###xml 88 104 88 104 <italic>Escherichia coli</italic>
###xml 88 104 <span type="species:ncbi:562">Escherichia coli</span>
Negative regulation of the pts operon by Mlc: mechanism underlying glucose induction in Escherichia coli.
###end article-title 123
###begin article-title 124
###xml 62 78 62 78 <italic>Escherichia coli</italic>
###xml 62 78 <span type="species:ncbi:562">Escherichia coli</span>
Metabolic switching in the sugar phosphotransferase system of Escherichia coli.
###end article-title 124
###begin article-title 125
###xml 31 51 31 51 <italic>Escherichia coli fis</italic>
###xml 31 47 <span type="species:ncbi:562">Escherichia coli</span>
Functional determinants of the Escherichia coli fis promoter: roles of -35, -10, and transcription initiation regions in the response to stringent control and growth phase-dependent regulation.
###end article-title 125
###begin article-title 126
###xml 115 137 115 137 <italic>Salmonella typhimurium</italic>
###xml 115 137 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Sugar transport by the bacterial phosphotransferase system. Phosphoryl transfer reactions catalyzed by enzyme I of Salmonella typhimurium.
###end article-title 126
###begin article-title 127
###xml 25 41 25 41 <italic>Escherichia coli</italic>
###xml 46 72 46 72 <italic>Corynebacterium glutamicum</italic>
###xml 25 41 <span type="species:ncbi:562">Escherichia coli</span>
###xml 46 72 <span type="species:ncbi:1718">Corynebacterium glutamicum</span>
Metabolic engineering of Escherichia coli and Corynebacterium glutamicum for biotechnological production of organic acids and amino acids.
###end article-title 127
###begin article-title 128
###xml 60 76 60 76 <italic>Escherichia coli</italic>
###xml 60 80 <span type="species:ncbi:83333">Escherichia coli K12</span>
Purification and characterization of adenylate cyclase from Escherichia coli K12.
###end article-title 128
###begin article-title 129
###xml 31 47 31 47 <italic>Escherichia coli</italic>
###xml 134 138 134 138 <italic>ptsG</italic>
###xml 31 52 <span type="species:ncbi:83333">Escherichia coli K-12</span>
Glucose transporter mutants of Escherichia coli K-12 with changes in substrate recognition of IICB(Glc) and induction behavior of the ptsG gene.
###end article-title 129
###begin p 130
Algorithm chart for computer-aided rational design of biochemical networks.
###end p 130
###begin p 131
###xml 47 55 47 55 <italic>E. coli.</italic>
###xml 57 58 57 58 <bold>A</bold>
###xml 304 305 304 305 <bold>B</bold>
###xml 47 54 <span type="species:ncbi:562">E. coli</span>
The modular architecture of the glucose PTS in E. coli. (A) Functional modules. The symbol '-' indicates modification. The arrows indicate various reactions: binding (), protein synthesis or conversion (), catalyzing a reaction (), suppressing protein synthesis (), and activating protein synthesis (). (B) The two major flux modules. The inner arrows are the accelerator flux module that goes through the plant, FB sensor, computer, and accelerator actuator modules; the outer arrows are the brake flux module that goes through the plant, FB sensor, computer, brake actuator, and accelerator actuator modules.
###end p 131
###begin p 132
###xml 182 183 182 183 <bold>A</bold>
###xml 207 210 207 210 <sup>Glc</sup>
###xml 279 282 279 282 <sup>Glc</sup>
###xml 327 330 327 330 <sup>Glc</sup>
###xml 349 350 349 350 <bold>B</bold>
###xml 410 411 410 411 <bold>C</bold>
###xml 494 498 494 498 <italic>ptsG</italic>
###xml 506 507 506 507 <bold>D</bold>
###xml 550 554 550 554 <italic>ptsG</italic>
###xml 556 560 556 560 <italic>ptsH</italic>
###xml 566 570 566 570 <italic>ptsI</italic>
###xml 599 603 599 603 <italic>ptsH</italic>
###xml 623 627 623 627 <italic>ptsG</italic>
###xml 652 656 652 656 <italic>ptsI</italic>
Simulated time course for molecular concentrations in response to glucose depletion in the PTS. The extracellular glucose concentration was changed from 0.2 M to 0.2 nM at 510 min. (A) Time evolution for IIAGlc protein in the phosphate relay cascade. The black line shows the IIAGlc concentration and the red line shows the IIAGlc-P concentration. (B) Time evolution for the intracellular cAMP concentration. (C) Time evolution for the concentration of the complex of Mlc and promoter 1 of the ptsG gene. (D) Time evolution for the expression of the ptsG, ptsH, and ptsI genes. The black line shows ptsH mRNA, the red line ptsG mRNA, and the blue line ptsI mRNA.
###end p 132
###begin p 133
###xml 39 40 39 40 <bold>A</bold>
###xml 297 298 297 298 <bold>B</bold>
###xml 303 306 303 306 <sup>Glc</sup>
###xml 457 460 457 460 <sup>Glc</sup>
###xml 511 514 511 514 <sup>Glc</sup>
###xml 553 554 553 554 <bold>C</bold>
###xml 560 564 560 564 <italic>ptsG</italic>
###xml 692 696 692 696 <italic>ptsG</italic>
###xml 740 743 740 743 <italic>mlc</italic>
Validation of the mathematical model. (A) The intracellular cAMP concentration and CRP:cAMP complex concentration were simulated with respect to the extracellular glucose concentration. The black line and red line show the cAMP concentration and the CRP:cAMP complex concentration, respectively. (B) IIAGlc protein phosphorylation was simulated with respect to the extracellular glucose concentration. The black line and red line show the phosphorylated IIAGlc protein concentration and the unphosphorylated IIAGlc protein concentration, respectively. (C) The ptsG mRNA concentration was simulated with respect to the extracellular glucose concentration. The black line and red line show the ptsG mRNA concentrations of wild type and of an mlc knockout mutant, respectively.
###end p 133
###begin p 134
###xml 11 15 11 15 <italic>ptsI</italic>
###xml 88 92 88 92 <italic>ptsI</italic>
###xml 274 275 274 275 <bold>A</bold>
###xml 281 284 281 284 <sup>Glc</sup>
###xml 387 390 387 390 <sup>Glc</sup>
###xml 422 423 422 423 <bold>B</bold>
###xml 428 431 428 431 <sup>Glc</sup>
###xml 533 536 533 536 <sup>Glc</sup>
###xml 576 577 576 577 <bold>C</bold>
###xml 724 725 724 725 <bold>D</bold>
###xml 870 871 870 871 <bold>E</bold>
###xml 895 896 895 896 <bold>F</bold>
Effects of ptsI gene amplification on the PTS components in the dynamic simulation. The ptsI gene concentration in a cell was changed within a range from 2.43 pM to 54.3 nM. The default concentration was 0.24 nM (one gene per a cell), as shown by the vertical dashed line. (A) IICBGlc protein phosphorylation. The black line and red line show the unphosphorylated and phosphorylated IICBGlc concentrations, respectively. (B) IIAGlc protein phosphorylation. The black line and red line show the unphosphorylated and phosphorylated IIAGlc protein concentrations, respectively. (C) HPr protein phosphorylation. The black line and red line show the unphosphorylated and phosphorylated HPr protein concentrations, respectively. (D) EI protein phosphorylation. The black line and red line show the unphosphorylated and phosphorylated EI protein concentrations, respectively. (E) Glucose uptake rate. (F) The cAMP and CRP:cAMP complex concentrations. The black line and red line show the cAMP and CRP:cAMP complex concentrations, respectively.
###end p 134
###begin p 135
###xml 68 72 68 72 <italic>ptsI</italic>
###xml 147 151 147 151 <italic>ptsI</italic>
Comparison of the specific glucose uptake between wild type and the ptsI-overexpressing mutant. The glucose uptake and cell growth of JM109/pUC118-ptsI (circle) and JM109/pUC118 (square) were measured under non-growing conditions. Three replicate experiments were performed and the averaged data are shown.
###end p 135
###begin p 136
Prediction of changes in the specific glucose uptake rate for mathematical mutants
###end p 136
###begin p 137
The values are the ratios of the specific glucose uptake rate for a mutant to that for wild type.
###end p 137
###begin p 138
###xml 0 1 0 1 <sup>a</sup>
###xml 5 8 5 8 <italic>mlc</italic>
###xml 8 9 8 9 <sup>&#8722;</sup>
###xml 36 39 36 39 <italic>mlc</italic>
aThe mlc- mutant indicates that the mlc gene is deleted.
###end p 138
###begin p 139
###xml 0 1 0 1 <sup>b</sup>
###xml 8 11 8 11 <italic>crp</italic>
###xml 11 12 11 12 <sup>+</sup>
###xml 24 27 24 27 <italic>crp</italic>
bIn the crp+ mutant the crp gene concentration is 10-fold higher than the wild type.
###end p 139
###begin p 140
###xml 0 1 0 1 <sup>c</sup>
cThe value was normalized by providing 1 to the ratio for wild type.
###end p 140
###begin p 141
Experimental results of growth, glucose uptake, specific glucose uptake, and cAMP concentration in growing cells
###end p 141
###begin p 142
###xml 20 23 20 23 <sub>600</sub>
cAMP, cyclic AMP; OD600, optical density at 600 nm.
###end p 142
###begin p 143
###xml 0 1 0 1 <sup>a</sup>
###xml 59 60 59 60 <italic>t</italic>
###xml 115 119 115 119 <italic>ptsI</italic>
aThe statistical significance was tested by the Bonferroni t-test. Except for the difference between MG1655 pUC118-ptsI and MG1655 M pUC118, all of the possible combination showed significant difference at least 5% level.
###end p 143
###begin p 144
n.t.: not tested.
###end p 144
###begin p 145
###xml 138 141 138 141 <sup>Glc</sup>
Prediction of changes in the specific glucose uptake rates in the improved dynamic model that excludes adenylate cyclase activation by IIAGlc-P
###end p 145
###begin p 146
The values are the ratios of the specific glucose uptake rate for a mutant to that of the wild type.
###end p 146
###begin p 147
###xml 0 1 0 1 <sup>a</sup>
###xml 5 8 5 8 <italic>mlc</italic>
###xml 8 9 8 9 <sup>&#8722;</sup>
###xml 36 39 36 39 <italic>mlc</italic>
aThe mlc- mutant indicates that the mlc gene is deleted.
###end p 147
###begin p 148
###xml 0 1 0 1 <sup>b</sup>
###xml 8 11 8 11 <italic>crp</italic>
###xml 11 12 11 12 <sup>+</sup>
###xml 24 27 24 27 <italic>crp</italic>
bIn the crp+ mutant the crp gene concentration is 10-fold higher than the wild type.
###end p 148
###begin p 149
###xml 0 1 0 1 <sup>c</sup>
cThe value was normalized by providing 1 to the ratio for wild type.
###end p 149
###begin p 150
Strains and plasmids used in this study
###end p 150

